Verrica Pharmaceuticals Inc Share Price

NASDAQ: VRCA

Small Cap

$4.76

-0.18

(-3.64%)

as on September 13, 2025 at 1:29 am IST

$₹

Verrica Pharmaceuticals Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's Low
Day's High
$4.74
Day's Price Range
$4.96
$4.76
0.42%
Downside
4.20%
Upside
52 Week's Low
52 Week's High
$3.82
52-Week Price Range
$20.13
$4.76
19.83%
Downside
322.84%
Upside

Verrica Pharmaceuticals Inc share price movements today

Previous Close: $4.94
Open: $4.94
Volume: 191.4K
Day's Low - High: $4.74 - $4.96
52 Week Low - High: $3.82 - $20.13

Verrica Pharmaceuticals Inc Historical Returns

1 Month Return: -20.3 %
3 Month Return: -23.77 %
1 Year Return: -75.89 %
3 Year Return: -87.5 %
5 Year Return: -94.7 %

Verrica Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Verrica Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$44.9M

EPS (TTM)

-0.65

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.2

Industry PE ratio

-3.8535542168674697

P/B Ratio

PEG Ratio

EBITDA

-37.1M

Revenue (TTM)

14.7M

Profit Margin

0.00%

Return On Equity TTM

14645600.00%

Verrica Pharmaceuticals Inc Stock Valuation

Track how Verrica Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Verrica Pharmaceuticals Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 15, 2025

Industry (-3.85x)

September 15, 2025

Today (-1.20x)

September 15, 2025

Highest (0.00x)

September 15, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.20x

Verrica Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Verrica Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Verrica Pharmaceuticals Inc	BUY	$44.9M	-94.7%	-1.2	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Verrica Pharmaceuticals Inc Stock including INR - Dollar returns

The Verrica Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Verrica Pharmaceuticals Inc investment value today

Current value as on today

₹29,148

Returns

₹70,852

(-70.85%)

Returns from Verrica Pharmaceuticals Inc Stock

₹75,838 (-75.84%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Verrica Pharmaceuticals Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Verrica Pharmaceuticals Inc. Average target price of $15

Verrica Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Verrica Pharmaceuticals Inc.

What analysts predicted

68.27%UPSIDE

Target Price

$15

Current Price

$4.76

Analyzed by

12 Analysts

Target

$15.00

Verrica Pharmaceuticals Inc target price $15, a slight upside of 68.27% compared to current price of $4.76. According to 12 analysts rating.

Verrica Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Verrica Pharmaceuticals Inc Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 16, 2025 to September 15, 2025

Change:-67% versus previous 30 day period

Verrica Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	0	2	1	3	5	-1	0	3	12
Gross Profit	0	0	2	1	2	4	-2	0	3	12
Operating Income	-7	-11	-23	-20	-18	-15	-20	-11	-8	1
EBITDA	-6	-10	-22	-22	-17	-14	-20	-13	-8	2
Interest Expense	0	-	1	2	2	2	2	2	2	2
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-10	-24	-24	-20	-17	-22	-16	-9	0
Income Tax Expense	0	0	0	0	0	-	0	0	-	-
Net Income	-6	-10	-24	-24	-20	-17	-22	-16	-9	0
Net Profit Margin	-17808.11%	-6038.46%	-850.26%	-1238.13%	-531.39%	-331.97%	1283.55%	-4709.88%	-283.28%	1.61%

Verrica Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	12	12	9	5	7
Gross Profit	-	-	0	0	0	11	8	4	5
Operating Income	-1	-4	-21	-30	-40	-30	-21	-65	-65
EBITDA	-1	-4	-20	-29	-39	-30	-21	-62	-65
Interest Expense	-	0	-	-	3	4	2	3	9
Depreciation	-	-	0	0	0	0	0	0	1
Income Before Tax	-1	-4	-20	-28	-42	-35	-24	-66	-76
Income Tax Expense	-1	-4	1	0	2	3	3	0	-
Net Income	-1	-4	-20	-27	-45	-35	-24	-66	-76
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-379.14%	-292.33%	-271.11%	-1307.47%	-1012.15%

Verrica Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-10	-24	-24	-20	-17	-22	-16	-9	0
Operating Cash Flow	-4	-14	-14	-19	-16	-8	-16	-12	-10
Investing Cash Flow	0	0	0	-	0	0	0	-	-
Financing Cash Flow	0	44	0	0	0	0	39	-4	-4
Change in Cash	-4	29	-14	-20	-17	-8	23	-16	-14

Verrica Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-4	-20	-28	-42	-35	-24	-66	-76
Operating Cash Flow	-4	-17	-27	-30	-27	-18	-38	-60
Investing Cash Flow	-79	-79	25	-3	0	54	0	0
Financing Cash Flow	12	99	0	35	33	-16	74	37
Change in Cash	8	1	-1	1	5	18	35	-23

Global Institutional Holdings in Verrica Pharmaceuticals Inc

Funds	Holdings
Caligan Partners LP	9.72%
Armistice Capital, LLC	9.26%
BOOTHBAY FUND MANAGEMENT, LLC	3.04%
Vanguard Group Inc	2.55%
BlackRock Inc	1.33%

See all

Insights on Verrica Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, -1.78M → 12.70M (in $), with an average increase of 260.2% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, -22.86M → 204.0K (in $), with an average increase of 1661.0% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 151.5%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 211.0%
NEGATIVE IMPACT
Price Dip
In the last 7 days, VRCA stock has moved down by -6.1%

About Verrica Pharmaceuticals Inc

verrica pharmaceuticals inc., a clinical stage medical dermatology company, develops and commercializes dermatological treatments in the united states. the company's lead product candidate include vp-102 that is in phase iii clinical trial for the treatment of molluscum contagiosum; in phase ii clinical trial for the treatment of common warts; and completed phase i clinical trial for the treatment of genital warts. it is also developing cantharidin-based product candidate, vp-103 for the treatment of plantar warts. the company has a license agreement with lytix biopharma as to develop and commercialize ltx-315 for dermatologic oncology indications. verrica pharmaceuticals inc. was founded in 2013 and is headquartered in west chester, pennsylvania.

Organisation	Verrica Pharmaceuticals Inc
Headquarters	44 West Gay Street, West Chester, PA, United States, 19380
Industry	Health Technology
CEO	Dr. Jayson M. Rieger M.B.A., Ph.D.
E-voting on shares	Click here to vote

Key Management of Verrica Pharmaceuticals Inc

Name	Title
Dr. Bradley J. Catalone MBA, Ph.D.	Head of Drug Development
Dr. Noah L. Rosenberg M.D.	Chief Medical Officer
Dr. Jayson M. Rieger M.B.A., Ph.D.	President, CEO & Director
Mr. John J. Kirby CPA	Interim Chief Financial Officer
Mr. David Zawitz	Chief Operating Officer
Mr. Eugene Scavola	Executive Vice President of Technical Operations

FAQs

What is Verrica Pharmaceuticals Inc share price today?

Verrica Pharmaceuticals Inc share price today is $4.76 as on September 13, 2025 at 1:29 am IST at the close of the market. Verrica Pharmaceuticals Inc share today touched a day high of $4.96 and a low of $4.74.

What is the 52 week high and 52 week low for Verrica Pharmaceuticals Inc share?

Verrica Pharmaceuticals Inc share touched a 52 week high of $20.13 on September 16, 2024 and a 52 week low of $3.82 on April 3, 2025. Verrica Pharmaceuticals Inc stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $4.76,which is 76.35% down from its 52 week high and 24.74% up from its 52 week low.

What is Verrica Pharmaceuticals Inc's market capitalisation today?

Verrica Pharmaceuticals Inc market capitalisation is $0.00T as on September 13, 2025 at 1:29 am IST.

How to invest in Verrica Pharmaceuticals Inc Stock (VRCA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Verrica Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Verrica Pharmaceuticals Inc Shares that will get you 0.3151 shares as per Verrica Pharmaceuticals Inc share price of $4.76 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Verrica Pharmaceuticals Inc Stock (VRCA) from India?

Indian investors can start investing in Verrica Pharmaceuticals Inc (VRCA) shares with as little as ₹88.141 or $1 (as of September 15, 2025 at 6:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Verrica Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 15, 2025 at 6:42 pm IST). Based on Verrica Pharmaceuticals Inc share’s latest price of $4.76 as on September 13, 2025 at 1:29 am IST, you will get 2.1008 shares of Verrica Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Verrica Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Verrica Pharmaceuticals Inc stock has given -94.7% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?